SkyWiseWin unicorn necklaces recalled due to cadmium in excess of… — recall 62255
Health Canada Consumer Product Safety · Canada · 2021-03-18
As described by Health Canada Consumer Product Safety: SkyWiseWin unicorn necklaces recalled due to cadmium in excess of allowable limits
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Health Canada's sampling and evaluation program has determined that the recalled jewellery contains cadmium in excess of allowable limits. Under the Children's Jewellery Regulations of the Canada Consumer Product Safety Act , it is illegal to import, advertise or sell jewellery items that appeal primarily to children under 15 years of age and contain more than 130 mg/kg total cadmium if the jewellery item is small enough to be totally enclosed in the small parts cylinder when a force of not more than 4.45 N is applied. Lead and cadmium are highly toxic, especially to children. A range of serious health effects have been associated with exposure to lead and cadmium, including anemia, vomiting, diarrhea, serious brain injury, convulsions, coma, as well as effects related to the liver, kidneys, heart and immune system. In extreme cases, there have been deaths. For more information on the risks and symptoms of lead exposure and cadmium exposure, visit the Government of Canada's website page Lead and cadmium in children's jewellery . As of March 16, 2021, Amazon has not received any reports of incidents or injuries for this product in Canada.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.